Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Torti

Showing results (121-130 of 263) with videos related to

Pageof 27
Sort By:
Clinical and Experimental Medicine|April 25, 2023
Interleukin-6<sup>2</sup>/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodiesSalvatore Rotundo, Massimo Borelli, Vincenzo Scaglione, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 11, 2005
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitorsCarlo Torti, Maria Cristina Uccelli, Eugenia Quiros-Roldan, et al.
AIDS (London, England)|November 18, 2011
Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmissionJoshua T Herbeck, Viktor Müller, Brandon S Maust, et al.
Antiviral Therapy|July 22, 2006
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapyGiuseppe Lapadula, Carlo Torti, Giuseppe Paraninfo, et al.
Le Infezioni in Medicina|September 24, 2015
Nasopharyngeal carcinoma: review of the literature with a focus on therapeutical implicationsAlessio Strazzulla, Giorgio Settimo Barreca, Aida Giancotti, et al.
The Journal of Antimicrobial Chemotherapy|September 9, 2016
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapyCarlo Mengoli, Samantha Andreis, Renzo Scaggiante, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2022
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2Salvatore Rotundo, Eleonora Vecchio, Antonio Abatino, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 23, 2018
Identification of human papillomavirus type 16 variants circulating in the Calabria region by sequencing and phylogenetic analysis of HPV16 from cervical smearsLuisa Galati, Michele Equestre, Roberto Bruni, et al.
BMC Infectious Diseases|October 18, 2019
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report seriesCarlo Torti, Maria Mazzitelli, Federico Longhini, et al.
Le Infezioni in Medicina|December 18, 2018
Prevalence of parasitic infections in migrants: do official symptom-driven guidelines apply to the current situation?Maria Mazzitelli, Carlo Torti, Giuseppe Greco, et al.
Pageof 27

Showing results (121-130 of 263) with videos related to

Sort By:
Pageof 27
Clinical and Experimental Medicine|April 25, 2023
Interleukin-6<sup>2</sup>/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodiesSalvatore Rotundo, Massimo Borelli, Vincenzo Scaglione, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 11, 2005
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitorsCarlo Torti, Maria Cristina Uccelli, Eugenia Quiros-Roldan, et al.
AIDS (London, England)|November 18, 2011
Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmissionJoshua T Herbeck, Viktor Müller, Brandon S Maust, et al.
Antiviral Therapy|July 22, 2006
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapyGiuseppe Lapadula, Carlo Torti, Giuseppe Paraninfo, et al.
Le Infezioni in Medicina|September 24, 2015
Nasopharyngeal carcinoma: review of the literature with a focus on therapeutical implicationsAlessio Strazzulla, Giorgio Settimo Barreca, Aida Giancotti, et al.
The Journal of Antimicrobial Chemotherapy|September 9, 2016
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapyCarlo Mengoli, Samantha Andreis, Renzo Scaggiante, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2022
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2Salvatore Rotundo, Eleonora Vecchio, Antonio Abatino, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 23, 2018
Identification of human papillomavirus type 16 variants circulating in the Calabria region by sequencing and phylogenetic analysis of HPV16 from cervical smearsLuisa Galati, Michele Equestre, Roberto Bruni, et al.
BMC Infectious Diseases|October 18, 2019
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report seriesCarlo Torti, Maria Mazzitelli, Federico Longhini, et al.
Le Infezioni in Medicina|December 18, 2018
Prevalence of parasitic infections in migrants: do official symptom-driven guidelines apply to the current situation?Maria Mazzitelli, Carlo Torti, Giuseppe Greco, et al.
Pageof 27